Aman Suresh Tharayil

Aman Suresh Tharayil

Auto-generated profile, based on publicly available information

Aman Suresh Tharayil

Dr. MGR Educational and Research Institute, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026
Verified
Book Chapter
Closed access
KVKiran K Veernapu
Kiran K Veernapu
BPBalkrishna Keshavrao Patil
Balkrishna Keshavrao Patil
ATAman Suresh Tharayil
Aman Suresh Tharayil
CSC.L Sindhura
C.L Sindhura
AAAdinarayana Andy
Adinarayana Andy
PRPrakash Raj
Prakash Raj
The integration of real-time artificial intelligence (AI) into Clinical Decision Support Systems (CDSS) marks a turning point in the evolution of modern healthcare. Traditional CDSS relied on retrospective or rule-based reasoning, offering insights only after data were finalized. In contrast, real-time AI enables continuous interpretation of live data streams from bedside monitors and laboratory systems to imaging and wearable devices transforming static analytics into adaptive, situational intelligence. This chapter examines how real-time AI can transition from successful experimentation to consistent clinical deployment. It explores the technical architectures that make real-time processing feasible, as well as the ethical, operational, and regulatory challenges that arise when algorithms move from laboratory settings to patient care environments.

16 June 2026
Verified
Book Chapter
Closed access
ABAnmol Shankarrao Budhewar
Anmol Shankarrao Budhewar
BPBalkrishna Keshavrao Patil
Balkrishna Keshavrao Patil
ATAman Suresh Tharayil
Aman Suresh Tharayil
SBSupriya Bhosale
Supriya Bhosale
SSSujitha Suthadevan
Sujitha Suthadevan
AAAdinarayana Andy
Adinarayana Andy
This chapter per the authors examines the integration of federated learning and digital twins to establish a resilient clinical intelligence ecosystem in the healthcare metaverse. While always-on sensing offers transformative potential, existing implementations often treat privacy, latency, and governance as secondary concerns. By synthesizing current literature, this chapter per the authors identifies a benchmarking gap where model metrics are prioritized over system-level evidence like communication overhead and energy costs. To address these deficiencies, authors propose a unified five-layer reference architecture treating trust and real-time synchronization as core requirements. This framework introduces the “protected twin” concept, utilizing differential privacy, secure aggregation, and audit trails to ensure distributed intelligence remains accountable and robust against poisoning. Ultimately, this chapter per the authors provides a strategic roadmap for moving toward deployable, clinically valid pipelines that balance innovation with patient safety.

30 June 2026
Verified
Book Chapter
Closed access
SSSayali K. Somwanshi
Sayali K. Somwanshi
ATAman Suresh Tharayil
Aman Suresh Tharayil
ABAnmol S. Budhewar
Anmol S. Budhewar
GVGnanavel Velu
Gnanavel Velu
DTDevi Thamizanban
Devi Thamizanban
VKVijay S. Karwande
Vijay S. Karwande
This chapter, per the authors, provides a comprehensive evaluation of Large Language Models (LLMs) within safety-critical healthcare environments, moving beyond traditional performance benchmarks toward a reliability-centered paradigm. The purpose of this chapter is to identify core clinical risks—including hallucinations, bias, uncertainty mismanagement, and privacy leaks—that can compromise patient safety despite high accuracy on standardized tests. Systematic principles for safety-critical assessment are established, emphasizing robustness, uncertainty awareness, and human-in-the-loop validation as essential for clinical trust. Furthermore, the authors discuss technical methods for stress testing and bias mitigation alongside the necessity of continuous monitoring, auditability, and lifecycle evaluation to handle model drift. By aligning these technical frameworks with emerging international regulatory standards, the chapter outlines a path for integrating clinical language models as dependable medical aids.

14 March 2025
Verified
Book Chapter
Closed access
Praveen Javali RPraveen Javali R
Praveen Javali R
RRRojin G Raj
Rojin G Raj
SSSwetaleena Shaw
Swetaleena Shaw
CDChingtham Henthoibi Devi
Chingtham Henthoibi Devi
AKAman Kumar
Aman Kumar
ATAman Suresh Tharayil
Aman Suresh Tharayil
This chapter explores the transformative role of virtual labs and simulation tools in enhancing STEM education. As digital platforms, these tools provide immersive, interactive, and accessible learning experiences that extend beyond the limitations of traditional classroom settings. The chapter delves into the myriad benefits of virtual labs, including increased accessibility and flexibility, cost-effectiveness, scalability, and the ability to offer personalized learning experiences. It also highlights how these tools improve student engagement, bridge the gap between theory and practice, and foster collaboration on both local and global scales. Further, the chapter presents detailed case studies from leading institutions such as the University of California, Berkeley; Georgia Institute of Technology; and Khan Academy, illustrating the successful integration and impact of virtual labs in diverse educational contexts.

2 May 2026
Verified
Book Chapter
Closed access
SKSreya Kosanam
Sreya Kosanam
RBRevathi Boyina
Revathi Boyina
AGA. M. T. Gurubasavaraj
A. M. T. Gurubasavaraj
KMK. M. D. Muzammil
K. M. D. Muzammil
Praveen Javali RPraveen Javali R
Praveen Javali R
ATAman Suresh Tharayil
Aman Suresh Tharayil
This chapter examines the scientific and clinical foundations of traditional herbal anxiolytics within the emerging field of neurophytomedicine. It explores the global prevalence and neurobiology of anxiety disorders, limitations of conventional pharmacological treatments, and the therapeutic potential of botanicals with historical use in anxiety relief. Emphasis is placed on phytochemical classes such as flavonoids, terpenes, alkaloids, and saponins, and their mechanisms of action on GABAergic, serotonergic, and hypothalamic pituitary adrenal systems. Comparative clinical evidence, safety considerations, herb-drug interactions, and regulatory frameworks are critically reviewed. The chapter also addresses challenges in standardization, placebo effects in trials, and ethical sourcing of medicinal plants. Finally, it outlines future directions including pharmacogenomic personalization, AI-driven phytochemical discovery, and integration of validated botanicals into mainstream psychiatry.

20 December 2024 in Biosciences Biotechnology Research Asia
Verified
Journal Article
Open access
LNLokesh Narayanaswamy
Lokesh Narayanaswamy
RMRakshitha Gonur Prakasha Murthy
Rakshitha Gonur Prakasha Murthy
NRNataraj Gowda Rajappa
Nataraj Gowda Rajappa
APAravind Patil
Aravind Patil
ATAman Suresh Tharayil
Aman Suresh Tharayil
VSVaishnavi Sairaman
Vaishnavi Sairaman
The investigation focused on assessing the prevalence of complications and predisposing factors, assessing the co-morbidities, and comparing the risk of age and complications as hypertension in CKD patients undergoing haemodialysis. A prospective observational investigation was undertaken across two separate sites. Basaveshwara Medical College & Hospital and Akshaya Global Hospital, Chitradurga. The data was collected in a pre-designed data collection form after obtaining the patient's consent. After the data collection, the information was entered into an Excel spreadsheet and subjected to analysis. The statistical analysis includes the calculation of percentages, the generation of descriptive statistics, and the computation of Pearson correlations. The study enrolled 70 patients; there were more multiple complications and predisposing factors compared to single complications and predisposing factors. The prevalence of complications such as muscle cramps (75.75%), followed by chills (47.10%), itching (38.50%), and hypotension (34.30%), was higher. While predisposing factors such as elevated blood pressure (88.6%) and diabetes mellitus (65.7%) were more commonly observed. Co-morbid conditions of hypertension and diabetes (47.15%) were found more. Insignificant correlation was found between age as a risk factor and hypertension as a complication. Our study concludes that muscle cramps, chills, itching, and hypotension were common complications, while hypertension and diabetes were frequent predisposing factors. Hypertension with diabetes was the most common comorbidity, and no significant age-related correlation with hypertension as a complication was observed.